Skip to main content
. 2020 Jul 21;10:12087. doi: 10.1038/s41598-020-68983-3

Figure 3.

Figure 3

Growth of E. coli after treatment with Innolysins Ec. Cleared fractions of muralytically active engineered proteins (see Fig. 2) were screened for the ability to inhibit growth of E. coli ATCC11303. Art-175 was provided by Lysando AG29 and used as a positive control. Phage T5 endolysin (T5 Lys) and receptor binding protein (Pb5) were used as negative controls. Growth inhibition was detected as the absence of growth (OD655nm) of cells treated with an Innolysin in comparison to the negative control (growth of ATCC11303 cells treated with cleared lysate of cells carrying the empty vector, pVTD) after incubation for 18 h at 37 °C. *Significant bacterial growth inhibition at P < 0.05.